Avita Medical Inc

AVITA Medical is a regenerative medicine company focused on the development and commercialization of innovative therapies with the power to transform lives. Harnessing the regenerative properties of a patient’s own skin, AVITA Medical’s RECELL^® System was approved by the U.S. Food and Drug Administration (FDA) in September 2018.

ASX Code
AVH

Sector
Pharmaceuticals- Biotechnology & Life Sciences

Website
https://avitamedical.com/

Spotlight Videos

Stocks of the Hour: Telix Pharmaceuticals, AVITA Medical, EZZ Life Science

May 31, 2024 - by Abbey Phillipps

A snapshot of the stocks on the move, featuring Telix Pharmaceuticals (ASX:TLX), AVITA Medical (ASX:AVH) and EZZ Life Science (ASX:EZZ).

Watch Now

News

RECELL boosts revenue, but AVITA feels the burn

November 8, 2024 - by Finance News Network

AVITA Medical (ASX:AVH), a leader in regenerative medicine with its proprietary RECELL technology, reported a substantial increase in revenue for the third quarter ended 30 September 2024.

Avita Medical Gives Shareholders a Lift

June 16, 2021 - by Glenn Dyer

Investors loved yesterday's June quarter update from biotech Avita Medical, in which the company raised its guidance due to the strength of orders for its flagship product Recell.

Burns Treatment A Hot Ticket For Avita

July 10, 2013 - by James Dunn

One of the largest sectors of the Australian stockmarket – at least in terms of number of companies – is life sciences. At last count, there were about 93 such companies.